Title : Alzheimer's patients can return to work after trying this new treatment
link : Alzheimer's patients can return to work after trying this new treatment
Alzheimer's patients can return to work after trying this new treatment
Alzheimer's disease (AD) is a progressive, degenerative disease (which means that worsen gradually over time), according to the National Institute of Health ( NIH ) affects about 5 million people in the United States. AD, however, not simply affect the patients themselves, but families who must care for them - and often institutionalized as the disease worsens and they become dangerous to themselves and others. Emotional and social impact of this disease is significant: the Alzheimer Foundation estimated to cost $ 60 billion in the US alone, including the cost of lost work by caregivers and medical and insurance costs. And the price tag is only expected to increase as the population ages.
A word about Alzheimer
This condition was named after Dr. Alois Alzheimer who was the first doctor to write a description of this disease date back to 1906. Back then known AD very little about, but when the doctor did an autopsy on the patient who was the study, it was found that the brains of patients had tangled with what later was called as amyloid plaques and tangles. Is the formation of these plaques and tangles that makes signs and symptoms of this disease.
The Alzheimer's Association ( AA ) indicates that this disease is the most common form of dementia, accounting for 60-80% of all cases of dementia, and is especially a risk for patients who are 65 years of age or older. The disease begins with symptoms such as mild memory loss. However, as you go, which it brings more serious memory problems, such as, difficulty speaking, communicating and even perform activities of daily living (such as eating, dressing, and toileting). Often, patients with moderate to severe forms of AD have to be placed in a care facility requiring 07.24.
Currently, there is no cure for AD. The FDA has approved four different drugs- Aricept, Exelon, Reminyl and Namenda- to treat the symptoms of this disease. However, they do not work for everyone and have a variety of unwanted side effects ranging from digestive problems (nausea, vomiting, diarrhea or constipation and loss of appetite) for mental problems like confusion.
New treatment brings new hope
Because of the side effects of drugs currently used for the EA, research is underway to find other treatments for this disease. A new study , recently published in the journal Aging has brought some excitement to the medical community and a new hope for Alzheimer's patients and those who love them.
The studio is on the small side, looking only 10 patients suffering from age-related loss of cognitive function. However, as the principal investigator Dale Breeden says the results are "unprecedented". Patients in this study were treated with a comprehensive program of 36 points which included everything from drugs and dietary supplements restrictions, brain stimulation and exercise. After completing this program, tests showed a reversal of its neurological degeneration and scientists note that "patients who had to stop work [because of their condition] were able to return to work and fighting for the work were able to improve their performance. " as an example, a man who shows a contraction hippocampal percentile was 17 to 75 percent in the size of the hippocampus after 10 months of treatment, according to MRIs performed before and after the study.
This multidisciplinary approach to neurological health is not the only interesting thing about this study. Scientists involved in this project also noted that this treatment is performed on patients who have one or two copies of APOE4 gene, which is involved in around 65% of Alzheimer's cases. Currently, patients are not tested for this gene because doctors say it is not necessary for this incurable disease, but researchers believe that in the future, the APOE4 evaluation will be carried out in order to help identify patients with genetic risk for AD and to help get early treatment they need to prevent this condition.
In summary, Alzheimer's disease is an incurable disease that has a devastating effect on patients, their families and society as a whole. Currently, the drugs to treat the symptoms of ADD approved by the FDA, not really affect a cure. That is why this study, though small, has high hopes for the future as researchers working toward a cure that will save patients and their families the emotional and social impact of this disease.
The Alzheimer's patients can return to work after trying this new treatment appeared for the first time in Lifehack .
The post Alzheimer's patients can return to work after trying this new treatment appeared first on http://feeds.lifehack.org/~r/LifeHack/~3/k5f3BmR8OIQ/alzheimers-patients-can-return-to-work-after-trying-this-new-treatment
Thanks for Reading Alzheimer's patients can return to work after trying this new treatment
You are now reading the article Alzheimer's patients can return to work after trying this new treatment Url Address https://exerciseplanstoloseweight.blogspot.com/2016/07/alzheimer-patients-can-return-to-work.html
0 Response to "Alzheimer's patients can return to work after trying this new treatment"
Posting Komentar